Search

everythinglearnresearchcommunity

for

Search:↓

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

CD34 marks potential stem cells in dog hair follicles.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

Stat3 affects skin cancer development by altering keratinocyte stem cell behavior.

Targeting colon cancer stem cells might lead to better treatment results.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

Human thymus has stem cells that can self-renew and maintain their identity.

Stat3 influences keratinocyte stem cell behavior, affecting differentiation and migration.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

Targeting specific T cells may help treat alopecia areata.

A specific group of skin stem cells was found to help maintain hair follicle cells.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

CDH3-related disease causes worsening eye and hair issues.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Desmocollin 1 and 3 have distinct patterns in human tissues, with Dsc1 in specific skin and hair layers and Dsc3 in various epithelial layers.

Cells that move well may improve hair loss treatments by entering hair follicles.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

Desmoglein 3 is important for keeping hair follicle stem cells inactive and maintaining their special properties.

Targeting ornithine decarboxylase can help prevent skin cancer.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

A new genetic mutation in the CDH3 gene causes hair loss and eye problems in young people.